Literature DB >> 17061333

Hepatic artery infusion as treatment of hepatic metastases from colorectal cancer.

M M Kemeny1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 17061333     DOI： 10.1016/s1091-255x(97)80128-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  9 in total

1.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.

Authors:  D C Hohn; R J Stagg; M A Friedman; J F Hannigan; A Rayner; R J Ignoffo; P Acord; B J Lewis
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

2.  Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.

Authors:  J K Martin; M J O'Connell; H S Wieand; R J Fitzgibbons; J A Mailliard; J Rubin; D M Nagorney; L K Tschetter; J E Krook
Journal:  Arch Surg       Date:  1990-08

3.  Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.

Authors:  M M Kemeny; H Battifora; D W Blayney; G Cecchi; D A Goldberg; L A Leong; K A Margolin; J J Terz
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

4.  Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.

Authors:  M M Kemeny; D Goldberg; J D Beatty; D Blayney; S Browning; J Doroshow; L Ganteaume; R L Hill; W A Kokal; D U Riihimaki
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

5.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Authors:  N Kemeny; K Seiter; D Niedzwiecki; D Chapman; E Sigurdson; A Cohen; J Botet; P Oderman; P Murray
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

6.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

7.  Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.

Authors:  P Rougier; A Laplanche; M Huguier; J M Hay; J M Ollivier; J Escat; R Salmon; M Julien; J C Roullet Audy; D Gallot
Journal:  J Clin Oncol       Date:  1992-07       Impact factor: 44.544

8.  Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

Authors:  P Piedbois; M Buyse; N Kemeny; P Rougier; R Carlson; T Allen-Mersh; M O'Connell; A Chang; V Sondak; M Kemeny; E Levy
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

9.  Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

Authors:  T G Allen-Mersh; S Earlam; C Fordy; K Abrams; J Houghton
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.